tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Financial Statements

Compare
118 Followers

Dermata Therapeutics Financial Overview

Dermata Therapeutics's market cap is currently $6.48M. The company's EPS TTM is $-21.424; its P/E ratio is ―; Dermata Therapeutics is scheduled to report earnings on March 31, 2025, and the estimated EPS forecast is $-1.50. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ -322.00$ -1.35K
Operating Income$ -8.04M$ -9.67M$ -7.86M$ -3.17M$ -4.47M
EBITDA$ 247.22K$ 0.00$ -7.86M$ -3.17M$ -4.47M
Net Income$ -7.79M$ -9.61M$ -7.95M$ -3.43M$ -4.97M
Balance Sheet
Cash & Short-Term Investments$ 7.44M$ 6.24M$ 10.80M$ 530.40K$ 1.99M
Total Assets$ 7.98M$ 6.94M$ 11.62M$ 605.45K$ 2.07M
Total Debt$ 0.00$ 0.00$ 0.00$ 3.55M$ 1.28M
Net Debt$ -7.44M$ -6.24M$ -10.80M$ 3.02M$ -708.06K
Total Liabilities$ 1.62M$ 922.63K$ 1.52M$ 3.78M$ 2.28M
Stockholders' Equity$ 6.36M$ 6.02M$ 10.11M$ -28.08M$ -24.84M
Cash Flow
Free Cash Flow$ -6.41M$ -8.83M$ -5.69M$ -4.03M$ -3.92M
Operating Cash Flow$ -6.41M$ -8.83M$ -5.69M$ -4.03M$ -3.92M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 7.61M$ 4.28M$ 15.96M$ 2.57M$ 4.73M
Currency in USD

Dermata Therapeutics Earnings and Revenue History

Dermata Therapeutics Debt to Assets

Dermata Therapeutics Cash Flow

Dermata Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis